PRESS RELEASE published on 08/14/2024 at 14:00, 7 months 26 days ago Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update Xenetic Biosciences, Inc. reports financial results for Q2 2024, focusing on DNase-based oncology program in preclinical studies with data due before year end. Ended quarter with $7.3M cash Financial Results Xenetic Biosciences Cash Balance DNase-based Oncology Program Preclinical Studies
BRIEF published on 05/22/2024 at 23:05, 10 months 17 days ago Xenetic Biosciences, Inc. annonce une transition de direction Développement Clinique Oncologie Leadership Executif Biosciences Xénétiques James Parslow
BRIEF published on 05/22/2024 at 23:05, 10 months 17 days ago Xenetic Biosciences, Inc. Announces Executive Leadership Transition Xenetic Biosciences Oncology Clinical Development Executive Leadership James Parslow
PRESS RELEASE published on 05/22/2024 at 23:00, 10 months 17 days ago Xenetic Biosciences, Inc. Announces Executive Leadership Transition Xenetic Biosciences appoints James F. Parslow as interim CEO. The company focuses on innovative immune-oncology technologies for hard-to-treat cancers Xenetic Biosciences Clinical Development Pancreatic Carcinoma James Parslow Immune-oncology Technologies
BRIEF published on 05/10/2024 at 14:35, 10 months 30 days ago Xenetic Biosciences publie ses résultats financiers et ses progrès commerciaux pour le premier trimestre 2024 Résultats Financiers Biosciences Xénétiques Programme D'oncologie Thérapie Basée Sur La DNase Etudes Précliniques
BRIEF published on 05/10/2024 at 14:35, 10 months 30 days ago Xenetic Biosciences Reports Q1 2024 Financial Results and Business Progress Financial Results Xenetic Biosciences Oncology Program DNase-based Therapy Preclinical Studies
PRESS RELEASE published on 05/10/2024 at 14:30, 10 months 30 days ago Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update Xenetic Biosciences, Inc. reports financial results for Q1 2024 and progress on DNase-based oncology program, including ongoing preclinical studies and funds of $7.8 million Financial Results Xenetic Biosciences DNase-based Oncology Program Preclinical Studies Cash Reserves
BRIEF published on 03/22/2024 at 13:05, 1 year ago Xenetic Biosciences, Inc. présente ses performances financières et ses progrès en matière de développement pour l'année 2023 Résultats Financiers Produits Biopharmaceutiques Biosciences Xénétiques Programme D'oncologie Plateforme DNase
BRIEF published on 03/22/2024 at 13:05, 1 year ago Xenetic Biosciences, Inc. Presents Full Year 2023 Financial Performance and Development Progress Financial Results Xenetic Biosciences Biopharmaceuticals Oncology Program DNase Platform
PRESS RELEASE published on 03/22/2024 at 13:00, 1 year ago Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results Xenetic Biosciences reports financial results for 2023, highlighting progress on DNase-based oncology program leading to Phase 1 study for pancreatic carcinoma & solid tumors, ending year with $9.0 million Financial Results Xenetic Biosciences Solid Tumors DNase-based Oncology Program Pancreatic Carcinoma
Published on 04/09/2025 at 15:35, 1 hour 50 minutes ago Le Cree Trappers Association, le Conseil de la sécurité économique des chasseurs cris et les sociétés d'exploration et minières approuvent le financement de 2025 pour poursuivre la reconstruction des camps incendiés lors des incendies de forêt de
Published on 04/09/2025 at 15:15, 2 hours 10 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 04/09/2025 at 15:00, 2 hours 25 minutes ago The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt During the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 15:00, 2 hours 25 minutes ago Le Cree Trappers Association, le Conseil de la sécurité économique des chasseurs cris et les sociétés d'exploration et minières approuvent le financement de 2025 pour poursuivre la reconstruction des camps incendiés lors des incendies de forêt de
Published on 04/09/2025 at 15:00, 2 hours 25 minutes ago The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt during the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 17:11, 13 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q1 2025 below market expectations; Full-year outlook unchanged
Published on 04/09/2025 at 17:11, 14 minutes ago Travis Perkins: Publication of Notice of Annual General Meeting to be held on Wednesday, 14 May 2025
Published on 04/09/2025 at 17:00, 25 minutes ago Not Just a Sporting Event, but Also a Technological Test: Insights into the World's First Human-Robot Co-Run Marathon
Published on 04/09/2025 at 15:35, 1 hour 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/09/2025 at 15:34, 1 hour 51 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 04/09/2025 at 11:24, 6 hours 1 minute ago Electricité de Strasbourg - Avis de réunion AGO du 14 mai 2025 publié au BALO
Published on 04/09/2025 at 09:00, 8 hours 25 minutes ago STEF : Avis de mise à disposition des comptes annuels 2024
Published on 04/09/2025 at 08:00, 9 hours 25 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
Published on 04/09/2025 at 08:00, 9 hours 25 minutes ago Museum Studio devient actionnaire majoritaire de Lord Cultural Resources
